Home Webtool Download Documentation Contact

Targets of perturbagens

Perturbagen ID : CID51622

Perturbagen : 17-ethinyl-3,17-estradiol; 17-ethinyl-3,17-oestradiol; 17-ethinylestradiol; 17alpha-ethinyl estradiol; 17α-ethynylestradiol; Cléo -35; Cryselle; Cyestra-35; Diane-35; Drospirenone and ethinyl estradiol; Drospirenone and ethinyl estradiol tablets 21; Drospirenone and ethinyl estradiol tablets 28; Drospirenone and ethinyl estradiol tablets usp (21-day regimen); Drospirenone and ethinyl estradiol tablets usp (28-day regimen); Elinest; Ethinyl estradiol; Ethinylestradiol; Ethinylestradiolum; Ethinyloestradiol; Ethynyl estradiol; Etinilestradiol; Evra -(6/0.60); Evra -(6/0.75); Gianvi; Lo-femenal 21 tablets; Lo/ovral-28; Loryna; Low-ogestrel; Mya; Nikki; Novo-cyproterone/ethinyl estradiol; Ocella; Ogestrel; Ortho evra; Ovral 21; Ovral 21 tab; Ovral 28 tablets; Ovral 28tab; Qismette 21; Qismette 28; Rajani; Ran-cyproterone/ethinyl estradiol; Syeda; Vestura; Xulane; Yasmin; Yasmin 21; Yasmin 28; Yasmin plus; Yaz; Yaz plus; Zamine 21; Zamine 28; Zarah; Zarah 21; Zarah 28

Target	Effect	Reference
AR	-1	DrugBank
NR3C2	-1	DrugBank
SRD5A1	-1	DrugBank
ESR1	1	DrugBank; STITCH; CLUE
NR1I2	1	DrugBank; STITCH; CLUE
PGR	1	DrugBank
ALB	2	DrugBank
CYP2C8	2	CLUE; STITCH
ESR2	2	CLUE; STITCH
KLK3	2	DrugBank
SHBG	2	DrugBank; STITCH